Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1022931-83-4

4-(BroMoMethyl)-2-fluoro-1-iodobenzene is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1022931-83-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1022931-83-4 Structure

  • Basic information

    1. Product Name: 4-(BroMoMethyl)-2-fluoro-1-iodobenzene
    2. Synonyms: 4-(BroMoMethyl)-2-fluoro-1-iodobenzene;3-Fluoro-4-iodobenzyl bromide;4-(Bromomethyl)-2-fluoro-1-iodobenzene, alpha-Bromo-3-fluoro-4-iodotoluene
    3. CAS NO:1022931-83-4
    4. Molecular Formula: C7H5BrFI
    5. Molecular Weight: 314.9214732
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1022931-83-4.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 4-(BroMoMethyl)-2-fluoro-1-iodobenzene(CAS DataBase Reference)
    10. NIST Chemistry Reference: 4-(BroMoMethyl)-2-fluoro-1-iodobenzene(1022931-83-4)
    11. EPA Substance Registry System: 4-(BroMoMethyl)-2-fluoro-1-iodobenzene(1022931-83-4)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1022931-83-4(Hazardous Substances Data)

1022931-83-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1022931-83-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,2,9,3 and 1 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1022931-83:
(9*1)+(8*0)+(7*2)+(6*2)+(5*9)+(4*3)+(3*1)+(2*8)+(1*3)=114
114 % 10 = 4
So 1022931-83-4 is a valid CAS Registry Number.

1022931-83-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(bromomethyl)-2-fluoro-1-iodobenzene

1.2 Other means of identification

Product number -
Other names 3-Fluoro-4-iodobenzyl bromide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1022931-83-4 SDS

1022931-83-4Relevant articles and documents

Stereoselective radiosynthesis of L- and D-3-[18F]fluoro-α-methyltyrosine

Castillo Meleán, Johnny,Humpert, Sven,Ermert, Johannes,Coenen, Heinz H.

, p. 202 - 207 (2015/08/19)

A three-step radiosynthesis is described which allows for the first time the preparation of L- and D-3-[18F]fluoro-α-methyltyrosine starting from [18F]fluoride. Corresponding 3-fluoro-4-formyl-benzylated Sch?llkopf derivatives were

COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE

-

Page/Page column 21, (2010/06/16)

Compounds of formula (I), and salts and solvates thereof are provided: Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.

COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE

-

Page/Page column 31, (2008/12/07)

A compound of formula (I) and salts thereof are provided: wherein A is defined in the specification. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1022931-83-4